However, the mechanism of IL‐23 in acute pancreatitis is still largely unclear; therefore, our study aimed to explore the regulatory upstream of IL‐23 in acute pancreatitis, leading to the development of a novel therapeutic approach or candidate drug to treat patients with acute pancreatitis. Here, IL23A is linked to acute pancreatitis.